EAN 2020 | PEARL study: fremanezumab for chronic or episodic migraine in the real world

Messoud Ashina, MD, PhD, DMSc, Faculty of Health and Medical Sciences, University of Copenhagen, Denmark, discusses the PEARL study protocol, a pan-European prospective observational study of fremanezumab effectiveness in patients with chronic or episodic migraine in the real world. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).